ValiRx Plc (LON:VAL)’s stock price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.17 and traded as low as $0.16. ValiRx shares last traded at $0.17, with a volume of 4,502,363 shares trading hands.
The company has a debt-to-equity ratio of 10.35, a quick ratio of 0.77 and a current ratio of 0.84. The firm has a market cap of $1.71 million and a price-to-earnings ratio of -0.18. The company’s fifty day moving average is GBX 0.17 and its two-hundred day moving average is GBX 0.33.
About ValiRx (LON:VAL)
ValiRx plc, a biotechnology oncology focused company, engages in developing novel treatments for cancer and associated biomarkers in the United Kingdom. Its proprietary GeneICE technology enables the selective silencing of specific genes by targeted histone deacetylation leading to chromatin condensation.
Featured Story: The basics of gap trading strategies
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.